Figures computed from official regulatory filings — methodology.
Statistical track record
FreeWin rates and median returns are available with a free account (5 insiders/month).
Create a free accountThis page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
| Company | Type | Value · USD | |
|---|---|---|---|
| ExerciseD | $8K | SEC | |
| Buy | $149.9 | SEC | |
| Exercise | $8K | SEC | |
| Buy | $930.1 | SEC | |
| Exercise | $8K | SEC | |
| ExerciseD | $8K | SEC | |
| Buy | $1.8K | SEC | |
| Buy | $2.7K | SEC | |
| Buy | $1.3K | SEC | |
| Award | $130K | SEC | |
| Award | $56K | SEC | |
| Award | $72.5K | SEC | |
| Other | $60K | SEC | |
| Buy | $180 | SEC | |
| Buy | $950 | SEC | |
| Buy | $4.1K | SEC | |
| Buy | $1.5K | SEC | |
| Buy | $2.4K | SEC | |
| Buy | $54K | SEC | |
| Buy | $360 | SEC | |
| Buy | $510 | SEC | |
| Buy | $850 | SEC | |
| Buy | $189.8 | SEC | |
| Buy | $200 | SEC | |
| Buy | $900 | SEC |